Poly Medicure Ltd

BSE
POLYMED •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Poly Medicure Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
90.04% Gain from 52W Low
32
TTM PE Ratio
Below industry Median
77.1
Price to Book Ratio
High in industry
13.5
Dividend yield 1yr %
Market Leader
0.1
TTM PEG Ratio
PEG TTM is much higher than 1
1.7
RSI
RSI is mid-range
57.7
MFI
MFI Overbought
78.3

Poly Medicure Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Poly Medicure Ltd shareholding Pattern

Promoter
66%
Foreign Institutions
9.9%
Mutual Funds
6.3%
Domestic Institutions
9.3%
Public
14.7%
Promoter
53.2%
Foreign Institutions
12.4%
Mutual Funds
5%
Domestic Institutions
7.2%
Public
27.2%
Promoter
53.2%
Foreign Institutions
14.1%
Mutual Funds
4.2%
Domestic Institutions
5.5%
Public
27.3%
Promoter
53.2%
Foreign Institutions
14.5%
Mutual Funds
4%
Domestic Institutions
5.2%
Public
27.2%
Promoter
53.3%
Foreign Institutions
15.6%
Mutual Funds
3.3%
Domestic Institutions
4.2%
Public
26.8%
Promoter
53.3%
Foreign Institutions
16.2%
Mutual Funds
3%
Domestic Institutions
3.7%
Public
26.8%

Poly Medicure Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
11
Bearish Moving Averages
5
5Day EMA
2,101.90
10Day EMA
2,093.20
12Day EMA
2,085.60
20Day EMA
2,049.50
26Day EMA
2,021.00
50Day EMA
1,921.30
100Day EMA
1,787.90
200Day EMA
1,626.00
5Day SMA
2,107.10
10Day SMA
2,115.60
20Day SMA
2,055.00
30Day SMA
2,002.10
50Day SMA
1,893.90
100Day SMA
1,729.60
150Day SMA
1,653.00
200Day SMA
1,603.30
Delivery & Volume
Resistance & Support
2,080.23
Pivot
Resistance
First Resistance
2,111.72
Second Resistance
2,149.58
Third Resistance
2,181.07
Support
First Support
2,042.37
Second support
2,010.88
Third Support
1,973.02
Relative Strength Index
57.71
Money Flow Index
78.26
MACD
64.66
MACD Signal
71.44
Average True Range
77.96
Average Directional Index
34.40
Rate of Change (21)
5.54
Rate of Change (125)
41.55
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Raaj Medisafe India Ltd.
-
-
-
Bilcare Ltd.
-
-
-
Nureca Ltd.
268.95
240.9
468.25
Medplus Health Services Ltd.
8026.4
597.95
977.45
Vasa Denticity Ltd.
-
-
-
Amkay Products Ltd.
-
-
-

Poly Medicure Ltd Company background

Founded in: 1995
Managing director: Himanshu Baid
Poly Medicure Limited was incorporated on 30th March 1995. The Company is a manufacturer/producer of Medical Devices. It manufactures and supply, in India and internationally, a diverse portfolio of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices and others. The Companys product portfolio comprises of more than 130 SKUs of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. It currently operate 10 manufacturing facilities across India, China, Egypt and Italy. In India, it operate 7 manufacturing facilities, four of which are situated at Faridabad (Haryana), and 2 in Jaipur (Rajasthan) and 1 in Haridwar (Uttarakhand). It operate 1 manufacturing facility in China through its wholly owned subsidiary Poly Medicure (Laiyang) Company Limited.The Company started commercial production by April 97 with an installed capacity of Medical Disposables (16500000 Nos ) and Cold/Hot Therapy Packs (500000 Nos).During the year 199798, the company produced 51.06 lac nos. of Medical Disposables which constitute 42.60% of the installed capacity utilisation. The company exported products of the value Rs. 50.28 lacs. The Company has been registered as an ISO 9002 company by SGS Yarsley International Certification Service Limited, United Kingdom.During the year 2003, the Company entered into a Joint Venture arrangement for putting up a plant in Egypt for manufacturing of various Medical Disposables. It has subscribed to 23% (6,90,000 Egyptian Pounds equivalent to Rs. 71,07,000/) of the share capital of the Joint Venture Entity. The Overseas Joint Venture is expected to commence commercial production during the current financial year.During the year 2005, it expanded installed capacity from 1000 lacs nos. to 1200 lacs nos. of Medical Disposables. The Company successfully implemented Quality Management System and has been accredited by SGS Yarsley International Certification Services, United Kingdom with ISO 9001:2000, ISO 13488:1996 and CE mark for some of its products. For the rest of the products, it has been accredited CE mark by DNV, Norway thus making the entire product range match up to International Quality Standards.In 2008, the Companys manufacturing unit located at Haridwar, Uttarakhand commenced its commercial operations.In 2010, the Company received Silver Patent Award by Department of Pharmaceutical Ministry of Chemicals and Fertilizers, Government of India and Pharmaceuticals Export Promotion Council in recognition of commendable contribution in Medical devices patent Category. It was also awarded by India Brand Equity Foundation (IBEF), in certificate of excellence in recognition of exemplary growth and sustainable success. As of March 31, 2015, Company had over 100 varieties of disposable medical devices, including veterinary disposable devices. In 2015, the manufacturing facility in Jaipur, Rajasthan commenced commercial operations.During the year 2018, the Companys wholly owned subsidiary, Poly Medicure B.V. Netherlands acquired 82% stake in Plan 1 Health s.r.l., an Italybased manufacturing company. Apart from this, it started manufacturing operations of new plant at IIT, in Faridabad effective from 28th February, 2018.The Company received Top Exporter Award by The Plastics Export Promotion Council, Dept of Commerce, Govt. of India, Star Performer Award by EEPC India Regional Award (Northern) for Export Excellence, Dare to Dream Award by ZEE Business in the category of emerging Company of the year and Export Excellence Award by FIA (Faridabad Industries Association), Haryana for the year 201819. The Company received the Medical Device Company of the Year 2018, award from Department of Pharmaceuticals, Government of India Biggest recognition and Achievement since inception of the company. The award was conferred based on Companys export performance, RD efforts and New Product launches. It was awarded Industrial Innovation Award by Confederation of Indian Industries (CII) on 18th December, 2019 for securing place among the top 25 innovative companies in 2019.The Company received the Forbes Asia Best under a Billion Award in 2020 as the regions top 200 small and midsized companies. The Company currently operate eight manufacturing facilities across India, China, Egypt and Italy. In India, it operate five manufacturing facilities, three of which are situated at Faridabad (Haryana), and one each in Jaipur (Rajasthan) and Haridwar (Uttarakhand). In addition, it is in the process of expanding the manufacturing capacities at facilities situated in Faridabad (Haryana) and Jaipur (Rajasthan). Apart from this, the Company operate one manufacturing facility in China through its whollyowned subsidiary Poly Medicure (Liayang) Company Limited that is certified to be compliant with Korea Good Manufacturing Practices by the Korea Food and Drug Administration, Ministry of Food and Drug Safety and has been accredited with a EC certificate for quality assurance system and EN ISO 13485:2016 for its quality management system. In addition, it operates one manufacturing facility in Assuit, Egypt, through our associate Ultra for Medical Products that is accredited with EC certificates or quality assurance system. It operate one manufacturing facility in Italy through stepdown subsidiary Plan1 Health S.R.L., which is accredited with EC certification for quality assurance system and EN 13485:2016 for its quality management system by DEKRA Certification B.V. Netherlands.The Company use different technologies for manufacturing different medical devices, including injection molding, extrusion, insert molding, blow molding, ultrasonic welding, UV bonding and laser welding and has expertise in handling different kind of specialized plastic materials. The manufacturing of components takes place on highly advanced PLC controlled plastic injection molding machines by using hot runner system or runner less mold technology, which is a clean technology and generates minimal scrap. Tubes are produced on highly accurate extruders with good yield. Its assembly machines are builtin with pokayoke features and vision inspection systems. The manufacturing facility is equipped with CNC controlled machines which enable accurate and efficient control over fabrication of molds. It further employ kaizen or lean manufacturing technology for cycle time reduction in various manufacturing processes.Its manufacturing process comprises of using raw materials in molding or tubing through extruders, following which components are assembled and samples are tested. The products are packed using a blister packing machine in duplex or correlated boxes and the final products undergo sterilization and quality checks. These include, automated arms installed at assembly machines, which are designed and programmed for specific assembly functions that may be deployed for various product variants. The manufacturing equipment is also supported by Servo systems that enable precise machine movements that improves accuracy in processes and limits generation of scrap.The Company operate the RD Centre at Faridabad, Haryana which is approved by DSIR. Our RD efforts are primarily focused on developing new products within existing product verticals as well as introduce products to enter into new product verticals, particularly focusing on fluid management within noncommunicable diseases segment, including oncology, nephrology and cardiology, and further improving existing processes and production cost efficiency. As of March 31, 2021, the Company had over 130 SKUs of medical devices. Besides this, it supplied products to over 110 countries, in Europe, Africa, Americas, Australia, and Asia through a network of over 220 distributors in these jurisdictions. The Companys Indian and International manufacturing facilities have been accredited with several international quality certifications. All manufacturing facilities have been accredited with the EC certificates for quality assurance systems and EN ISO 13485:2016 certifications. Further, Faridabad Facilities and Haridwar Facility, have also been accredited with management system certificates for compliance with ISO 9001:2015.
Read More

Poly Medicure Ltd FAQs

The past 1-year return of Poly Medicure Ltd [POLYMED] share was 87.09. The Poly Medicure Ltd [POLYMED] share hit a 1-year low of Rs. 1092.35 and a 1-year high of Rs. 2235.3.

The Mutual Fund Shareholding was 6.29% at the end of .

You can easily buy Poly Medicure Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -